Anika Therapeutics, Inc. (NASDAQ:ANIK) Q2 2025 Earnings Call Transcript July 30, 2025
Anika Therapeutics, Inc. reports earnings inline with expectations. Reported EPS is $-0.13 EPS, expectations were $-0.13.
Operator: Good morning, ladies and gentlemen, and welcome to Anika’s second quarter earnings conference call. I will now turn the call over to Matt Hall, Director, Corporate Development and Investor Relations. Please proceed.
Matt Hall: Thank you. Good morning, and thank you for joining...
